葛兰素史克(GSK)股吧_葛兰素史克怎么样_分析讨论社区

列表
摘要

发新帖

发表新帖
问董秘
发起斗股

阅读	评论	标题	作者	最后更新
3043	13	全球首项乙肝功能性治愈药物三期数据来了：这类患者治愈率可达35%	葛兰素史克资讯	05-28 08:08
384	1	乙肝功能性治愈里程碑：GSK 新药 III 期大获成功，中国亚组治愈率35%！	摩熵医药	05-29 04:00
37	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	06-01 10:48
31	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	06-01 10:02
105	0	迈科康IPO：带状苞疹疫苗接近商业化，保护率相当但安全性超过葛兰素史克竞品，后者去年销售额328亿元	挖贝网	06-01 04:32
37	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-28 06:15
42	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-27 10:36
43	0	Specialized disclosure report	葛兰素史克资讯	05-27 04:16
218	0	礼来豪掷38亿美元连吞三家公司抢跑下一轮全球疫苗竞赛	葛兰素史克资讯	05-26 11:12
39	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-26 10:26
37	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-26 10:19
114	0	Kepler Cheuvreux大幅上调葛兰素史克目标价至2516便士	格隆汇	05-26 08:54
44	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-22 07:21
45	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-20 10:43
44	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-20 10:41
61	0	极具潜力石墨烯概念牛股：华丽家族、宝泰隆、恒天海龙、中国宝安、中国动力等等	股海无边666	05-20 01:43
50	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-19 11:03
182	0	重磅ADC药物获批多发性骨髓瘤二线联合用药，GSK中国特药业务部负责人：肿瘤是未来GSK重要增长引擎之一	葛兰素史克资讯	05-19 03:53
44	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-18 11:05
49	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-18 06:31
339	0	葛兰素史克RSV疫苗获批新人群	个股解码局	05-18 02:53
780	0	葛兰素史克RSV疫苗在日获批扩大适用人群	葛兰素史克资讯	05-18 02:35
849	0	百亿ADC抗癌药赛道迎新玩家，药企期待多元化支付提高可及性	葛兰素史克资讯	05-15 06:36
50	0	Quarterly report filed by institutional managers, Holdings	葛兰素史克资讯	05-15 04:51
51	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-15 12:26
1157	1	正大天晴携手葛兰素史克推进乙肝新药上市	个股解码局	05-12 12:25
574	4	中国生物制药涨超4%：牵手GSK合作乙肝临床治愈明星产品	中国生物制药资讯	05-11 08:05
1080	0	中国生物制药与GSK就全球首款乙肝治愈药物达成合作；药易购收到深交所监管函丨医药早参	中国生物制药资讯	05-12 07:06
50	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-11 11:02
412	1	正大天晴与葛兰素史克达成独家合作将加快引进新型乙肝创新药	中国生物制药资讯	05-11 07:21
52	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-11 06:44
54	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-11 06:33
321	0	牵手GSK，中国生物制药拿下这款乙肝潜在治愈药物中国代理权	中国生物制药资讯	05-11 05:29
348	0	中国生物制药牵手葛兰素史克布局乙肝新药在华商业化	中国生物制药资讯	05-11 12:41
1800	4	中国生物制药：正大天晴与葛兰素史克达成一项独家战略合作加速bepirovirsen在中国内地的上市进程	中国生物制药资讯	05-11 12:17
288	0	中国生物制药：正大天晴与葛兰素史克达成一项独家战略合作	中国生物制药资讯	05-11 12:36
142	0	中国生物制药(01177)与葛兰素史克达成独家战略合作	智通财经	05-11 12:30
423	0	中国生物制药：与葛兰素史克达成bepirovirsen独家战略合作	中国生物制药资讯	05-11 12:23
116	0	中国生物制药(01177.HK)与葛兰素史克达成独家战略合作加速bepirovirsen中国内地上市进程	格隆汇	05-11 12:19
131	0	中国生物制药：附属公司正大天晴药业集团股份有限公司与葛兰素史克达成一项独家战略合作，加速bepirovirsen在中国内地的上市进程	格隆汇	05-11 12:15
67	0	买就跌，卖就涨。买到假货了	霑洽轰5	05-08 05:35
589	1	时安生物与GSK就寡核苷酸新药达成超10亿美元授权合作；莎普爱思终止购买上海勤礼实业100%股权｜医药早参	葛兰素史克资讯	05-07 07:05
59	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-07 01:54
56	0	Statement of Beneficial Ownership by Certain Investors	葛兰素史克资讯	05-06 11:23
643	2	花旗集团将葛兰素史克目标股价从2250便士下调至2100便士	葛兰素史克资讯	05-06 01:20
62	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-06 12:57
58	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-01 11:15
51	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	05-01 11:10
52	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-30 12:31
109	0	【图解财报】葛兰素史克一季报盈利17.37亿英镑，同比增加6.96%	葛兰素史克资讯	04-29 10:39
74	1	什么原因低开	陈Cian	04-29 09:39
54	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-29 08:12
178	0	新掌门首份成绩单亮眼：HIV与抗癌药立功葛兰素史克(GSK.US)Q1营收利润双超预期	智通财经	04-29 03:09
791	1	葛兰素史克第一季度营收76.3亿英镑预估76.1亿英镑	葛兰素史克资讯	04-29 02:10
54	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-28 11:20
55	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-28 07:26
2770	2	从“抗艾第一股”到小核酸新贵前沿生物股价与业绩齐飞靠GSK千万美元授权金逆势涨停	前沿生物-U资讯	04-27 07:27
62	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-27 08:15
53	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-27 07:01
63	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-24 11:23
62	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-23 06:11
60	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-22 06:10
62	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-21 06:12
77	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-21 12:49
112	0	玛贝兰妥单抗联合方案获批，治疗二线及以上多发性骨髓瘤成年患者	葛兰素史克资讯	04-20 06:53
58	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-20 06:39
65	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-20 06:21
159	0	倍乐锐获批用于治疗二线及以上多发性骨髓瘤成年患者	葛兰素史克资讯	04-20 03:58
76	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-17 06:22
136	0	葛兰素史克(GSK.US)Belantamab mafodotin(玛贝兰妥单抗)在华获批上市	智通财经	04-17 04:51
127	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-17 01:02
66	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-16 06:45
77	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-15 06:41
69	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-15 06:15
69	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-14 11:26
63	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-14 06:48
4625	26	批签发下滑、企业承压 HPV疫苗市场遇冷？	万泰生物资讯	04-10 07:09
79	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-13 11:19
70	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-13 06:26
68	0	Report of foreign issuer [Rules 13a-16 and 15d-16]	葛兰素史克资讯	04-13 06:11

emytylist